1656
R. Zimmer et al.
PAPER
Table 5 1H NMR Data of Lactams 4
Product
1H NMR (300 MHz, CDCl3/TMS); , J (Hz)
4aa
(cis)
7.42–7.08 (m, 6 H, C6H5, NH), 3.93 (dd, J = 6, 10, 1 H, 1’-H), 3.84 (s, 3 H, OCH3), 3.41 (dd, J = 10, 14, 1 H, 2’-H), 3.30 (dd, J =
6, 14, 1 H, 2’-H), 2.98 (d, J = 8.5, 1 H, 2-H), 2.39 (dd, J = 7, 13.5, 1 H, 4-H), 2.32–2.19 (m, 2 H, 3-H, 4-H), 1.32 (s, 9 H, t-C4H9),
0.95 (d, J = 6.5, 3 H, 3-CH3)
4aa
(trans)
7.35 (s, 1 H, NH), 7.32–7.15 (m, 5 H, C6H5), 3.97 (dd, J = 5.5, 11, 1 H, 1’-H), 3.86 (s, 3 H, OCH3), 3.47 (dd, J = 11, 14, 1 H, 2’-
H), 3.36 (dd, J = 5.5, 14, 1 H, 2’-H), 2.73 (d, J = 4, 1 H, 2-H), 2.60 (dd, J = 9, 17, 1 H, 4-H), 2.25–2.18 (m, 1 H, 3-H), 1.86 (dd, J
= 5, 17, 1 H, 4-H), 1.32 (s, 9 H, t-C4H9), 0.76 (d, J = 7, 3 H, 3-CH3)
4ab,c
7.09, 6.55 (2 br s, 0.5 H each, NH), 3.71, 3.67 (2 s, 1.5 H each, OCH3), 3.53 (d, J = 3, 0.5 H, 2-H), 2.68 (dd, J = 8.5, 17, 0.5 H, 2’-
H), 2.38 (d, J = 7.5, 0.5 H, 2-H), 1.37, 1.36 (2 s, 4.5 H each, t-C4H9), 1.06, 0.86 (2 d, J = 6.5, 7, 1.5 H each, 3-CH3)
4ba
(cis)
8.16 (br s, 1 H, NH), 7.55–6.98 (m, 6 H, arom CH, NH), 4.11 (dd, J = 5, 11, 1 H, 1’-H), 3.86 (s, 3 H, OCH3), 3.59 (dd, J = 11, 15,
1 H, 2’-H), 3.43 (dd, J = 5, 15, 1 H, 2’-H), 3.08 (d, J = 9, 1 H, 2-H), 2.33 (dd, J = 8.5, 16.5, 1 H, 4-H), 2.08 (dd, J = 11.5, 16.5, 1
H, 4-H), 2.03–1.92 (m, 1 H, 3-H), 1.26 (s, 9 H, t-C4H9), 0.88 (d, J = 7, 3 H, 3-CH3)
4ba
(trans)
8.55 (br s, 1 H, NH), 7.55–6.98 (m, 6 H, arom CH, NH), 4.09 (dd, J = 5, 11, 1 H, 1’-H), 3.87 (s, 3 H, OCH3), 3.67 (dd, J = 11, 15,
1 H, 2’-H), 3.45 (dd, J = 5, 15, 1 H, 2’-H), 2.67 (d, J = 4, 1 H, 2-H), 2.55 (dd, J = 9, 17, 1 H, 4-H), 2.18–2.13 (m, 1 H, 3-H), 1.78
(dd, J = 5, 17, 1 H, 4-H), 1.28 (s, 9 H, t-C4H9), 0.50 (d, J = 7, 3 H, 3-CH3)
4bb,d
8.60 (br s, 1 H, NH), 7.54, 7.51 (br s, 1 H, NHindol), 3.80, 3.85 (2 s, 3 H, OCH3), 0.89, 0.55 (2 d, J = 7 each, 3 H, 3-CH3)
4ca
7.25 (s, 1 H, NH), 4.41 (q, J = 7.6, 1 H, 1’-H), 4.02 (d, J = 9, 1 H, 2-H), 3.77 (s, 3 H, OCH3), 2.74–2.67 (m, 1 H, 3-H), 2.45 (dd, J
(cis)
= 8.5, 16.6, 1 H, 4-H), 2.23 (dd, J = 11.3, 16.6, 1 H, 4-H), 1.43 (d, J = 7.7, 3 H, 2’-H), 1.35 (s, 9 H, t-C4H9), 1.13 (d, J = 7, 3 H, 3-
CH3)
4c
(trans)
6.80 (s, 1 H, NH), 4.07 (q, J = 7.2, 1 H, 1’-H), 3.77 (s, 3 H, OCH3), 3.57 (d, J = 3.1, 1 H, 2-H), 2.67 (dd, J = 8.3, 16.8, 1 H, 4-H),
2.48–2.43 (m, 1 H, 3-H), 1.93 (dd, J = 3.7, 16.8, 1 H, 4-H), 1.42 (d, J = 7.2, 3 H, 2’-H), 1.34 (s, 9 H, t-C4H9), 1.22 (d, J = 7, 3 H,
3-CH3)
4da
(major)
7.58 (s, 1 H, NH), 7.31–7.25, 7.14–7.12 (2 m, 3 H, 2 H, C6H5), 3.88–3.86 (m, 1 H, 1’-H), 3.86 (s, 3 H, OCH3), 3.40 (dd, J = 11.4,
13.8, 1 H, 2’-H), 3.31 (dd, J = 5, 13.8, 1 H, 2’-H), 2.92 (q, J = 3.8, 1 H, 2-H), 2.41–2.34, 2.25–2.19, 2.03–1.88 (3 m, 1 H, 1 H, 2
H, 3-H, 4-H), 1.30 (s, 9 H, t-C4H9)
4db
3.85 (s, 3 H, OCH3), 1.29 (s, 9 H, t-C4H9)
(minor)
4e
7.63, 6.87 (2 br s, 0.36 H, 0.64 H, NH), 4.18–4.03, 3.73–3.60 (2 m, 1 H each, CH), 3.79, 3.80 (2 s, 3 H each, OCH3), 2.59–2.05 (m,
4 H, CH2), 1.90–0.85 (m, 12 H, CH3, with s at = 1.36, t-C4H9)
4f
6.81, 6.45 (2 br s, 0.85 H, 0.15 H, NH), 4.48 (dd, J = 3, 9, 0.15 H, 2-H), 4.11 (dd, J = 3, 9.5, 0.85 H, 2-H), 4.06 (d, J = 7.5, 1 H, 1’-
H), 3.77, 3.72 (2 s, 2.55 H, 0.45 H, OCH3), 2.69–2.51, 2.41–2.25, 2.21–1.95 (3 m, 1 H, 2 H, 2 H, 3-H, 4-H, 2’-H), 1.62–1.51 (m,
1 H, 3’-H), 1.37, 1.35 (2 s, 7.65 H, 1.35 H, t-C4H9), 1.19–1.02 (m, 1 H, 3’-H), 0.96 (d, J = 7, 1 H, 2’-CH3), 0.88 (t, J = 7.5, 1 H, 4’-H)
a Recorded on a 500 MHz spectrometer.
b Missing signals are hidden by the signals of the major isomer.
c Overlapped with signals of both 4% diastereomers of 4a.
d Overlapped with signals of both 3% diastereomers of 4b.
13C NMR (75.5 MHz, CDCl3): (major diastereomer) = 175.6,
171.7, 168.6 (3 s, CO2Me, CON), 135.9, 128.8, 128.6, 127.1 (s, 3 d,
C6H5), 70.5 (d, C-2), 55.4 (d, C-1’), 52.5 (q, OCH3), 51.7, 28.6 [s,
q, C(CH3)3], 44.4 (t, C-4), 37.3 (s, C-3), 34.5 (t, C-2’), 29.7, 23.9 (2
q, 3-CH3); (minor diastereomer) = 174.7, 171.0, 168.5 (3 s,
CO2Me, CON), 136.7, 129.2, 128.8, 127.1 (s, 3 d, C6H5), 74.5 (d, C-
2), 58.6 (d, C-1’), 52.8 (q, OCH3), 51.1, 28.6 [s, q, C(CH3)3], 45.1
(t, C-4), 36.4 (s, C-3), 34.7 (t, C-2’), 29.7, 24.4 (2 q, 3-CH3).
2-(2-tert-Butylcarbamoylpyrrolidin-1-yl)-3-phenylpropan-1-ol
(5d)
To a solution of the isomerically pure lactam 4d (0.030 g, 0.086
mmol) in anhyd THF (2 mL) was added LiAlH4 (0.026 g, 0.688
mmol) and the suspension was stirred for 16 h at r.t. Then the reac-
tion mixture was carefully treated with H2O (0.03 mL), aq 2 N
NaOH solution (0.06 mL) and again with H2O (0.03 mL). After ex-
traction with EtOAc (3 5 mL) the combined organic phases were
dried (Na2SO4) and concentrated to provide the crude product
(0.030 g). Purification by colum chromatography (silica gel,
EtOAc–MeOH, 95:5) afforded 0.021 g (81%) of 5d as colorless
crystals, mp 125–127 °C; [ ]D22 +37.6 (c = 0.34, CHCl3).
1H NMR (300 MHz, CDCl3): = 7.41 (s, 1 H, NH), 7.31–7.14 (m,
5 H, C6H5), 3.63–3.49 (m, 2 H, 1’-H), 3.33 (dd, J = 4, 9.7 Hz, 1 H,
2-H), 3.12–3.06, 3.01–2.93, 2.85–2.73 (3 m, 4 H, 5-H, 2’H, 3’-H),
2.55 (dd, J = 9.8, 13.4 Hz, 1 H, 3’-H), 2.14–1.67 (m, 5 H, 3-H, 4-H,
OH), 1.31 (s, 9 H, t-C4H9).
IR (neat): = 3330 (N–H), 3100–2940 (=C–H, C–H), 1730 (C=O,
ester), 1700 (C=O, lactam), 1675 cm–1 (C=O, amide).
MS (EI, 70 eV): m/z (%) = 734 (M+, 1), 276 (15), 274 (70), 214 (15),
91 (12), 57 (15), 41 (13), 32 (100), 26 (13).
Anal. Calcd for C21H30N2O4 (374.5): C, 67.36; H, 8.07; N, 7.48.
Found C, 67.70; H, 8.56; N, 7.95.
Synthesis 2001, No. 11, 1649–1658 ISSN 0039-7881 © Thieme Stuttgart · New York